Dermatology Question of the Week: Deductive Dermpath

This week's question will focus on dermatopathology.
Dermatology Question of the Week: Deductive Dermpath
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

A 10-year-old patient presents to your office with the following red papule on their nose. A shave biopsy shows a proliferation of melanocytes.

Which of the following features would be reassuring for a Spitz nevus rather than melanoma? (hint: more than one may be correct)

A. Loss of p16

B. Sharply circumscribed

C. High mitotic rate

D. Vertically oriented nests with clefting

E. Presence of Kamino bodies 

 

Rationale: Spitz nevi were characterized by Dr. Sophie Spitz in 1948. Spitz nevi exist upon a spectrum of melanocytic neoplasms which include atypical Spitz tumor and Spitzoid melanoma. Identification is important as Spitz nevi typically have very, very low risk of progression by comparison to melanoma. Several features to distinguish the features have been described. Clinically, Spitz nevi present as a dome-shaped papule less than 1cm in size that may be darkly pigmented or have more of a reddish/skin-colored appearance.

Correct answers: B, D, E

Spitz nevi are characterized by multiple features including their sharply circumscribed nature, vertically oriented nests with clefting, and eosinophilic hyaline granules known as Kamino bodies. Additional features and comparisons to atypical Spitz tumor and Spitzoid melanoma are shown in the table below.

Table 27-19 Comparison of Spitz Nevus, Atypical Spitz Tumor, and Spitz Melanoma

  SPITZ NEVUS ATYPICAL SPITZ TUMOR SPITZ MELANOMA
Clinical features

Mean and median age 21 years (range 2 to 69 years)

Extremities most common

Pink or reddish plaque, papule, or nodule

Any age, younger patients <40 years

Extremities, trunk

Plaque or nodule

Color variegation

Any age, often >40 years

Extremities, trunk

Asymmetrical

Enlarged plaque or nodule

Color variegation

Changing lesion

Histopathology

Size <5 to 6 mm

Symmetrical

Well circumscribed

Epidermal hyperplasia

Vertically oriented nests with clefting

Central focal pagetoid spread if any

Often wedge shaped

Maturation of dermal component

Few or no dermal mitoses (0 to 2 per mm2)

Often >5 to 10 mm Symmetrical or asymmetrical

Well or poorly circumscribed

Ulceration possible

Irregular nesting

Greater cellularity

Greater pagetoid spread

Deeper dermal extension

Maturation may be partial or absent

Dermal mitoses 2 to 6 per mm2

Deep mitoses

Possible necrosis

>5mm, often >10 mm

Often asymmetrical

Often poorly circumscribed

Ulceration

Irregular and confluent nesting

Pagetoid spread may be extensive

Ulceration

Effacement of epidermis

Lack of maturation

Dermal mitoses often >6 per mm2

Mitoses deep/marginal, or atypical

Necrosis

Cytology

Enlarged epithelioid/spindle cells

Little or no nuclear pleomorphism

Absence of high-grade cytological atypia

Enlarged epithelioid/spindle cells

Nuclear enlargement, pleomorphism, hyperchromasia

Enlarged epithelioid/spindle cells

High-grade cytological atypia

Immunohistochemistry

HMB45 and Ki67 expression diminished with depth in dermal component

Ki67 index low (<5%)

HMB45 and Ki67 expression diminished or variable with depth

Ki67 index low or intermediate (5% to 15%)

HMB45 and Ki67 deep expression often

Elevated Ki67 proliferative index (>20 %)

p16 expression may be diminished or absent

Molecular

Array CGH: isolated gains of 7p, 11q, tetraploidy

HRAS-activating mutations

Kinase fusions

Array CGH: often 1 or multiple chromosomal abnormalities

Kinase fusions

PTEN mutations

Heterozygous or homozygous loss of 9p21 may occur

Array CGH: multiple chromosomal abnormalities

Kinase fusions

BRAF, NRAS mutations rare

HRAS mutations rare

PTEN mutations

Homozygous loss of 9p21

TERT promoter mutations

Prognosis Very low (almost no) risk of progression

Low risk of progression

Almost always indolent

Clinical recurrences occur

Regional clinical lymph node metastases occur

Rare distant metastases and death

Abbreviation: array CGH = comparative genomic hybridization.

 

Incorrect answers: 

A. Loss of p16. Loss of p16 is a feature of melanoma whereas retention of p16 is a feature of Spitz nevus. p16 is located on chromosome 9 and is encoded by the CDKN2A gene. p16 functions as a tumor suppressor, hence the loss of p16 in melanoma leads to lack of tumor suppression which is not a finding typically seen in Spitz nevi. 

C. High mitotic rate. Spitz nevi typically have a very low mitotic rate. 

 

Additional reading at Barnhill's Dermatopathology Chapter 27: Tumors of Melanocytes

Create a Free MyAccess Profile

AccessMedicine Network is the place to keep up on new releases for the Access products, get short form didactic content, read up on practice impacting highlights, and watch video featuring authors of your favorite books in medicine. Create a MyAccess profile and follow our contributors to stay informed via email updates.